- Home
- SRCE vs TVTX Comparison
SRCE vs TVTX Comparison
Compare SRCE & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRCE
- TVTX
- Stock Information
- Founded
- SRCE 1863
- TVTX 2008
- Country
- SRCE United States
- TVTX United States
- Employees
- SRCE N/A
- TVTX N/A
- Industry
- SRCE Major Banks
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- SRCE Finance
- TVTX Health Care
- Exchange
- SRCE Nasdaq
- TVTX Nasdaq
- Market Cap
- SRCE 1.4B
- TVTX 1.5B
- IPO Year
- SRCE N/A
- TVTX N/A
- Fundamental
- Price
- SRCE $57.85
- TVTX $18.37
- Analyst Decision
- SRCE Hold
- TVTX Buy
- Analyst Count
- SRCE 2
- TVTX 12
- Target Price
- SRCE $64.75
- TVTX $24.58
- AVG Volume (30 Days)
- SRCE 62.4K
- TVTX 1.2M
- Earning Date
- SRCE 01-23-2025
- TVTX 02-13-2025
- Dividend Yield
- SRCE 2.49%
- TVTX N/A
- EPS Growth
- SRCE 2.45
- TVTX N/A
- EPS
- SRCE 5.25
- TVTX N/A
- Revenue
- SRCE $369,012,000.00
- TVTX $203,447,000.00
- Revenue This Year
- SRCE N/A
- TVTX $62.38
- Revenue Next Year
- SRCE $1.11
- TVTX $57.65
- P/E Ratio
- SRCE $11.03
- TVTX N/A
- Revenue Growth
- SRCE 1.57
- TVTX 57.08
- 52 Week Low
- SRCE $47.30
- TVTX $5.12
- 52 Week High
- SRCE $68.13
- TVTX $20.33
- Technical
- Relative Strength Index (RSI)
- SRCE 43.01
- TVTX 52.05
- Support Level
- SRCE $56.77
- TVTX $16.80
- Resistance Level
- SRCE $59.08
- TVTX $18.76
- Average True Range (ATR)
- SRCE 1.46
- TVTX 0.90
- MACD
- SRCE 0.18
- TVTX 0.02
- Stochastic Oscillator
- SRCE 69.79
- TVTX 61.57
About SRCE 1st Source Corporation
1st Source Corp along with its subsidiary offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans which are given to privately owned business clients mainly located within regional market area, Consumer Services that consists of full range of consumer banking products and services, Trust and Wealth Advisory Services and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.